Vedana Therapeutics launches to develop migraine therapies
Memento Medicines launches with $93m to develop antibody therapy for retinal diseases
Meteor Biotech joins brain organoids consortium
Can food influence gene activity?
Experimental drug protects body from harmful effects of gluten
Japanese pharma companies shifting to earlier CDMO outsourcing
Promising cell model for dementia research
Antibodies offer hope for autoimmune diseases
New lung cancer model reveals tumour location shapes the immune response
ADHD-related traits may intensify chronic pain
Hidden mechanism in DNA damage
Base to Base biotech podcast 56: GRIN genes and relapsing MS